Gabapentin
- Product NDC
- 80425-0149
- 11-digit product format
- 804250149
- Labeler code
- 80425
- Product ID
- 80425-0149_ed11a31c-6509-35b6-e053-2995a90a768d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Advanced Rx Pharmacy of Tennessee, LLC
- Application
- ANDA075477
- Marketing category
- ANDA
- Marketing start
- 2020-01-01
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 80425-0149-1 | 80425014901 | 30 CAPSULE in 1 BOTTLE (80425-0149-1) | 30 capsule | 2020-01-01 | 0000-00-00 | No | No | Current |
| 80425-0149-2 | 80425014902 | 60 CAPSULE in 1 BOTTLE (80425-0149-2) | 60 capsule | 2020-01-01 | 0000-00-00 | No | No | Current |
| 80425-0149-3 | 80425014903 | 90 CAPSULE in 1 BOTTLE (80425-0149-3) | 90 capsule | 2020-01-01 | 0000-00-00 | No | No | Current |